Biphasic activation of extracellular signal-regulated kinase (ERK) 1/2 in epidermal growth factor (EGF)-stimulated SW480 colorectal cancer cells
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Cancer cells have different characteristics due to the genetic differences where these unique features may strongly influence the effectiveness of therapeutic interventions. Here, we show that the spontaneous reactivation of extracellular signalregulated kinase (ERK), distinct from conventional ERK activation, represents a potent mechanism for cancer cell survival. We studied ERK1/2 activation in vitro in SW480 colorectal cancer cells. Although ERK signaling tends to be transiently activated, we observed the delayed reactivation of ERK1/2 in epidermal growth factor (EGF)-stimulated SW480 cells. This effect was observed even after EGF withdrawal. While phosphorylated ERK1/2 translocated into the nucleus following its primary activation, it remained in the cytoplasm during late-phase activation. The inhibition of primary ERK1/2 activation or protein trafficking, blocked reactivation and concurrently increased caspase 3 activity. Our results suggest that the biphasic activation of ERK1/2 plays a role in cancer cell survival; thus, regulation of ERK1/2 activation may improve the efficacy of cancer therapies that target ERK signaling.
Abstract
Cancer cells have different characteristics due to the genetic differences where these unique features may strongly influence the effectiveness of therapeutic interventions. Here, we show that the spontaneous reactivation of extracellular signalregulated kinase (ERK), distinct from conventional ERK activation, represents a potent mechanism for cancer cell survival. We studied ERK1/2 activation in vitro in SW480 colorectal cancer cells. Although ERK signaling tends to be transiently activated, we observed the delayed reactivation of ERK1/2 in epidermal growth factor (EGF)-stimulated SW480 cells. This effect was observed even after EGF withdrawal. While phosphorylated ERK1/2 translocated into the nucleus following its primary activation, it remained in the cytoplasm during late-phase activation. The inhibition of primary ERK1/2 activation or protein trafficking, blocked reactivation and concurrently increased caspase 3 activity. Our results suggest that the biphasic activation of ERK1/2 plays a role in cancer cell survival; thus, regulation of ERK1/2 activation may improve the efficacy of cancer therapies that target ERK signaling.
참고문헌 (28)
- Yang SH, "Transcriptional regulation by the MAP kinase signaling cascades", Gene, 320, pp.3~21 (2003)
- Chuderland D, "Identification, characterization of a general nuclear translocation signal in signaling proteins", Mol Cell, 31, pp.850~861 (2008)
- Zeldich E, "Enamel matrix derivative stimulates human gingival fibroblast proliferation via ERK", J Dent Res, 86, pp.41~46 (2007)
- Huang Z, "Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation", J Biol Chem, 276, pp.21351~21358 (2001)
- Nakayama K, "FGF induces oscillations of Hes1 expression, Ras", ERK activation, 2008, pp.18, R332~R334
- Sastre AP, "Requirement of an intermediate gene expression for biphasic ERK1", 2 activation in thrombin-stimulated vascular smooth muscle cells, 2008, pp.283, 25871~25878
- Sancho E, "Signaling pathways in intestinal development, cancer", Annu Rev Cell Dev Biol, 20, pp.695~723 (2004)
- Roberts PJ, "Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer", Oncogene, 26, pp.3291~3310 (2007)
- Lefloch R, "Single, combined silencing of ERK1, ERK2 reveals their positive contribution to growth signaling depending on their expression levels", Mol Cell Biol, 28, pp.511~527 (2008)
- Traverse S, "Sustained activation of the mitogen-activated protein(MAP)kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor, epidermal growth factor", Biochem J, 288(Pt 2) (1992)
- Sparmann A, "Ras-induced interleukin-8 expression plays a critical role in tumor growth, angiogenesis", Cancer Cell, 6 (2004)
- Skarpen E, "MEK1and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments", FASEB J, 22, pp.466~476 (2008)
- Franke TF, "PI3K", Akt, apoptosis: size matters, 2003, pp.22, 8983~8998
- Murphy LO, "Molecular interpretation of ERK signal duration by immediate early gene products", Nat Cell Biol, 4, pp.556~564 (2002)
- Jones SM, "Growth-factor-dependent mitogenesis requires two distinct phases of signalling", Nat Cell Biol, 3, pp.165~172 (2001)
- Casar B, "Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes", Mol Cell, 31, pp.708~721 (2008)
- Cheng C, "A positive feedback loop couples Ras activation, CD44alternative splicing", Genes Dev, 20, pp.1715~1720 (2006)
- Monick M, "Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase", J Immunol, 166, pp.2681~2687 (2001)
- Sorkin A, "Endocytosis, signalling: intertwining molecular networks", Nat Rev Mol Cell Biol, 10, pp.609~622 (2009)
- Volmat V, "The nucleus, a site for signal termination by sequestration, inactivation of p42", p44MAP kinases, 2001, pp.114, 3433~3443
- Grammer TC, "Evidence for MEKindependent pathways regulating the prolonged activation of the ERK-MAP kinases", Oncogene, 14, pp.1635~1642 (1997)
- Balciunaite E, "PDGF initiates two distinct phases of protein kinase C activity that make unequal contributions to the G0 to S transition", Curr Biol, 10, pp.261~267 (2000)
- Jones SM, "PDGF induces an early, a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1", Curr Biol, 9, pp.512~521 (1999)
- Nakanishi M, "Roles of cPLA2alpha, arachidonic acid in cancer", Biochim Biophys Acta, 1761, pp.1335~1343 (2006)
- Soydan AS, "High molecular weight phospholipase A2, fatty acids in human colon tumours, associated normal tissue", Eur J Cancer, 32A, pp.1781~1787 (1996)
- Ballif BA, "Molecular mechanisms mediating mammalian mitogen-activated protein kinase(MAPK)kinase(MEK)-MAPK cell survival signals", Cell Growth Differ, 12, pp.397~408 (2001)
- Sharma SV, "Oncogene addiction:setting the stage for molecularly targeted cancer therapy", Genes Dev, 21, pp.3214~3231 (2007)
- Fang JY, "The MAPK signalling pathways, colorectal cancer", Lancet Oncol, 6, pp.322~327 (2005)